Does the NBA have a problem on its hands, in regards to performance-enhancing drugs? The explanations would vary, depending on who you ask. But two weeks and three suspensions into the season, the league has to at the very least entertain the question Continue reading →

Q3 2019 NewLink Genetics Corp Earnings Call AMES Nov 10, 2019 (Thomson StreetEvents) -- Edited Transcript of NewLink Genetics Corp earnings conference call or presentation Wednesday, November 6, 2019 at 1:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Carl W. Continue reading →

LOS ANGELES: Wellness brand HUM Nutrition, the leader in the beauty vitamin and supplement category, launches its latest revolutionary product, MIGHTY NIGHT, to boost skin cell renewal during sleep. Mighty Night uses clean, clinically proven ingredients in effective dosages that work while you sleep resulting in a fresh complexion each morning. The proprietary formula boosts overnight renewal by supporting skin cell turnover, scavenging free radicals, promoting optimal sleep and improving skin texture. Continue reading →

The worldwide market for Endocrine System Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019. Access Report Details at: https://www.themarketreports.com/report/global-endocrine-system-drug-market-by-manufacturers-regions-type-and-application-forecast Market share of global Endocrine System Drug industry is dominate by companies like Novo Nordisk, Sanofi, Merck, Eli Lilly, AstraZeneca, AbbVie and others which are profiled in this report as well in terms of Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) Continue reading →

Alps Advisors Inc. reduced its holdings in shares of Eli Lilly And Co (NYSE:LLY) by 31.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,138 shares of the companys stock after selling 10,377 shares during the period Continue reading →

Elmwood Park, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and womens health division, GenPath, today announced the presentation of new research from its genetics program at the National Society for Genetic Counselors (NSGC) 38th Annual Conference in Salt Lake City, UT from November 5-8. Multiple poster presentations will demonstrate the companys commitment to advancing the research of rare genetic disorders and hereditary conditions, and supporting the genetic counseling community. Continue reading →